AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+14.47%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.73B
AUM Growth
+$4.73B
(+8.1%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
47.54%
Holding
160
New
25
Increased
29
Reduced
25
Closed
13
Top Buys
| 1 |
Intel
INTC
|
$51.2M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$43.8M |
| 3 |
argenx
ARGX
|
$41.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.5M |
| 5 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$37.3M |
Top Sells
| 1 |
GDS Holdings
GDS
|
$73M |
| 2 |
Zillow
Z
|
$58.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$52.2M |
| 4 |
Alibaba
BABA
|
$46.5M |
| 5 |
uniQure
QURE
|
$25.3M |
Sector Composition
| 1 | Healthcare | 82.42% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Technology | 2.06% |
| 4 | Communication Services | 0.94% |
| 5 | Real Estate | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
26
DELISTED
ChemoCentryx, Inc.
CCXI
| $38.4M | 0.68% |
750,000
+100,000
| +15% | +$5.12M |
|
|
ITOS
27
DELISTED
iTeos Therapeutics
ITOS
| $37.4M | 0.66% |
1,094,047
| – | – |
|
|
ACHL
28
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $37.3M | 0.66% |
+2,255,375
| New | +$37.3M |
|
29
Amicus Therapeutics
FOLD
$2.42B
| $37.1M | 0.65% |
3,750,000
+1,250,000
| +50% | +$12.4M |
|
|
IMAB
30
I-MAB
IMAB
$372M
| $36.4M | 0.64% |
750,000
+25,000
| +3% | +$1.21M |
|
31
Broadcom
AVGO
$1.41T
| $34.8M | 0.61% |
+75,000
| New | +$34.8M |
|
|
CERE
32
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $34.3M | 0.61% |
2,500,000
+217,900
| +10% | +$2.99M |
|
33
KE Holdings
BEKE
$21.9B
| $34.2M | 0.6% |
600,000
-400,000
| -40% | -$22.8M |
|
34
Avis
CAR
$5.54B
| $32.6M | 0.58% |
+450,000
| New | +$32.6M |
|
|
TPTX
35
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $29.6M | 0.52% |
312,700
-37,300
| -11% | -$3.53M |
|
|
SWTX
36
DELISTED
SpringWorks Therapeutics
SWTX
| $29.4M | 0.52% |
400,000
-50,000
| -11% | -$3.68M |
|
37
Atara Biotherapeutics
ATRA
$87.7M
| $28.7M | 0.51% |
2,000,000
-800,000
| -29% | -$11.5M |
|
38
Denali Therapeutics
DNLI
$2.23B
| $28.6M | 0.5% |
500,000
+100,000
| +25% | +$5.71M |
|
|
FMTX
39
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $28M | 0.5% |
1,000,000
+500,000
| +100% | +$14M |
|
|
TRIL
40
DELISTED
Trillium Therapeutics Inc.
TRIL
| $26.9M | 0.47% |
2,500,000
+400,000
| +19% | +$4.3M |
|
41
Praxis Precision Medicines
PRAX
$973M
| $24.6M | 0.43% |
750,000
| – | – |
|
42
Replimune Group
REPL
$455M
| $24.4M | 0.43% |
800,000
+100,000
| +14% | +$3.05M |
|
43
Vor Biopharma
VOR
$252M
| $23.7M | 0.42% |
+550,000
| New | +$23.7M |
|
44
Adverum Biotechnologies
ADVM
$66.5M
| $23.7M | 0.42% |
2,400,000
-100,000
| -4% | -$986K |
|
|
NEXI
45
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $22.9M | 0.4% |
+1,200,000
| New | +$22.9M |
|
46
NovaGold Resources
NG
$2.7B
| $22.8M | 0.4% |
2,600,000
| – | – |
|
47
Foghorn Therapeutics
FHTX
$300M
| $22.7M | 0.4% |
1,720,720
| – | – |
|
|
SQZ
48
DELISTED
SQZ Biotechnologies Company
SQZ
| $22M | 0.39% |
1,606,309
+1
| +0% | +$14 |
|
49
Gossamer Bio
GOSS
$582M
| $21.8M | 0.39% |
2,358,968
| – | – |
|
|
ALBO
50
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $21.2M | 0.37% |
600,000
-100,000
| -14% | -$3.53M |
|